Cardica completes enrollment in MAGIC trial Cardica announced that the company has completed enrollment in the Multicenter Assessment of Grafts in Coronaries, or MAGIC, trial, its post market surveillance study for the long-term evaluation of bypass grafts completed using C-Port Distal Anastomosis Systems. Cardica's C-Port systems are automated stapling devices used to connect graft vessels during a heart bypass procedure. "The long-term evaluation of the C-Port systems is expected to provide solid data surrounding the use of this device to perform an automated anastomosis during bypass procedures," said the company.
News For CRDC From The Last 14 Days
Check below for free stories on CRDC the last two weeks.